Live Breaking News & Updates on Tennor Therapeutics Suzhou

Stay updated with breaking news from Tennor therapeutics suzhou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Helicobacter Pylori Infection Pipeline Insight Report 2024: Insights About 5+ Companies and 5+ Pipeline Drugs Featuring TenNor Therapeutics, Servatus Biopharmaceuticals, and TenNor Therapeutics

Helicobacter Pylori Infection Pipeline Insight Report 2024: Insights About 5+ Companies and 5+ Pipeline Drugs Featuring TenNor Therapeutics, Servatus Biopharmaceuticals, and TenNor Therapeutics
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Route Of Administration , Tennor Therapeutics Suzhou , Pipeline Development Activities , Tennor Therapeutics Inc , Pylori Infection Pipeline Insight Report , Insights About , Pipeline Drugs Featuring Tennor Therapeutics , Servatus Biopharmaceuticals , Tennor Therapeutics , Pylori Infection , Helicobacter Pylori Infection , Helicobacter Pylori , Pipeline Development , Nor Therapeutics ,

TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases


TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases
News provided by
Share this article
Share this article
SUZHOU, China, Jan. 18, 2021 /PRNewswire/  TenNor Therapeutics (Suzhou) Limited, a clinical-stage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses, announced today that it has entered into a research collaboration agreement with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson. As part of the agreement, the parties plan to utilize a multitargeting drug conjugation platform developed by TenNor to discover new therapies for the treatment of nontuberculous mycobacteria (NTM) diseases. The agreement was facilitated by Johnson & Johnson Innovation LLC. ....

Tennor Therapeutics , Johnson Innovation , Janssen Pharmaceuticals Inc , Tennor Therapeutics Suzhou , Janssen Pharmaceutical Companies Of Johnson , Janssen Pharmaceuticals , Janssen Pharmaceutical Companies , Nor Therapeutics , Tennor Therapeutics Limited , ஜான்சன் கண்டுபிடிப்பு , ஜான்சன் மருந்துகள் இன்க் , ஜான்சன் மருந்து நிறுவனங்கள் ஆஃப் ஜான்சன் , ஜான்சன் மருந்துகள் , ஜான்சன் மருந்து நிறுவனங்கள் , அல்லது சிகிச்சை ,